
CVC-backed Evonik announces IPO
CVC Capital Partners-backed German chemicals maker, Evonik Industries, has confirmed plans to float in the Prime Standard segment of the Frankfurt stock exchange.
The move, which followed a period of hesitation sparked by difficult market conditions, is now scheduled to take place before the summer-break and could see one of the biggest IPOs in Germany in the last decade, valuating the business at up to €10bn.
Klaus Engel, executive board chairman of Evonik said in a statement today: "Despite the challenging conditions on the financial markets, we are entering the intensive phase of preparations for the planned stock exchange listing with great confidence."
CVC owns a 25% stake in the business, which it acquired for €2.4bn in 2008. The majority is owned by the RAG Foundation, which was set up by the government in 2007 to ease the social costs and liabilities associated with the ending of subsidised coal mining in 2018.
Deutsche Bank and Goldman Sachs Group will be global coordinators and together with Bank of America Merrill Lynch, Credit Suisse and JPMorgan will act as book runners for the planned IPO.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater